Edit Module

USDA-Approved FeLV, FIV Drug Available Online



Published:

Veterinarians may now order Lymphocyte T-Cell Immunomodulator (LTCI) -- reportedly the first United States Department of Agriculture (USDA) approved treatment for Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV) -- directly from the manufacturer, T-Cyte Therapeutics.

Veterinarians can order the product at the company website or by phone. The streamlined ordering process means practitioners and animal clinics can expedite treatment of FeLV and FIV.

“We’ve worked hard to build a process that streamlines access to the product, provides pertinent, practical and accurate information regarding the treatment of FeLV and FIV and gives veterinarians’ direct-source access to LTCI,” says Dr. Beardsley. “Ordering LTCI from T-Cyte will be efficient for veterinarians and can be a life-saver for sick pets. The site will also make it easier for pet owners to locate local veterinarians who have treated cats suffering from these diseases. The website will be a one-stop data source to aid in the treatment of FeLV and FIV.”

The site also features educational and product information about retroviral health care and a nationwide, searchable database of veterinary clinics that offer LTCI is in the works. 

LTCI was briefly distributed by Imulan and most recently by AgriLabs, who successfully introduced and marketed LTCI to the veterinary profession. Visit Tcyte.com for product information and ordering, or call (800) 483-2104.

<Home>

Edit Module
Edit ModuleShow Tags

Archive »Read More

Where Did All the Vet Techs Go?

NATVA's 2016 survey reveals the challenges vet techs face, which leads to high turnover.

Mazuri Launches Veterinarian Resource Center Facebook Page

The page will provide exotic animal practitioners articles, facts, success stories, management tips.

NIH Issues Grant to Further Canine Cancer Research

The grant, awarded to various colleges and groups, will fund a study aimed at understanding the interactions between cancer and the immune system in dogs with naturally occurring tumors. The researchers will then apply that knowledge to the understanding of human cancer.

Add your comment:
Edit Module
Edit Module
Edit ModuleEdit ModuleShow Tags Edit Module
Edit Module Edit Module
Edit ModuleShow Tags

Events


Show More...
Edit Module
Edit Module